Latest filing published 08 Dec 2017 for PharMerica CORP, €699k.
No signal scores available.
This profile gathers the share dealings of Robert E. Dries across 2 companies, led by PharMerica Corp and Tivity Health, Inc. Between 22 August 2016 and 7 December 2017, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 8 December 2017: a transaction of €699k, in PharMerica Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations